New drug cocktail shows promise in preventing transplant complications
Disease control
Completed
This study tested whether a combination of two drugs, cyclophosphamide and bortezomib, could prevent graft-versus-host disease (GVHD) in 23 adults with blood cancers who received a stem cell transplant. GVHD is a serious condition where donor cells attack the patient's body. The …
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC